Teva Group and Actavis Generics - Company Facts & Figures

Teva is committed to developing and producing innovative and quality medicines for the patients we serve around the world. This is how we are helping people to live healthier lives.

01

Enabling access to quality medicines and treatment options

1,800
medicines
43,000
employees
200,000,000
people served every day

PT Actavis Indonesia site is a member of the Teva Group’s global operations network, which are routinely inspected for quality and good manufacturing practices by our global Quality Assurance team.

Quality control is not only from the global Teva Group, but also includes audits by the regulatory authorities of countries that market pharmaceutical products manufactured by PT Actavis Indonesia, such as Russia, Ukraine and many more.

In an effort to improve quality and capacity in producing international quality medicines, Actavis made major changes and improvements to our facility’s infrastructure, supporting equipment, production machinery and quality management. In recent years, PT Actavis Indonesia has also installed significant funds in conducting renovations in production buildings.

View the full Infographic
02

Focused specialty leadership centered on core therapeutic areas

Migraine and headache

Pain

Movement disorders and neurodegeneration

Respiratory

03

Global generic leadership

$
Billion
55
XXX
XXX

Top 3 leadership position in over 25 markets

1 in 10
XXX
04

Global Reach

60
Commercial presence in 60 Markets
3,500
Portfolio of different products globally
05

A fully integrated R&D function

25 R&D and clinical development sites.

270
Pending product registrations pending FDA approva
550
Over pending product approvals in International Markets
450
Generic launches globally in 2018
06

Strong operational base and global infrastructure and scale

70
production sites
120
billion tablets & capsules annually